Loading...
Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study
BACKGROUND. Direct-acting antivirals (DAA) allow effective and safe eradication of hepatitis C virus (HCV) in most patients. There are limited data on the long-term effects of all-oral, interferon-free DAA combination therapies in kidney transplant (KT) patients infected with HCV. Here we evaluated...
Na minha lista:
| Udgivet i: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7004590/ https://ncbi.nlm.nih.gov/pubmed/32095505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000954 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|